Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension

NCT01353274 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1157

Last updated 2014-08-18

Study results available
· View outcomes & findings →

Summary

Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension

Conditions

Interventions

DRUG

Micamlo

Telmisartan plus Amlodipine T40/A5

Sponsors & Collaborators

Principal Investigators

  • Boehringer Ingelheim · Boehringer Ingelheim

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01353274 on ClinicalTrials.gov